Ipratropium Bromide



Ipratropium Bromide





(i pra troe’ pee um)

Apo-Ipravent (CAN), Atrovent, Atrovent HFA, Gen-Ipratropium (CAN), ratio-Ipratropium (CAN), ratio-Ipratropium UDV (CAN)

PREGNANCY CATEGORY B


Drug Classes

Anticholinergic

Antimuscarinic

Bronchodilator

Parasympatholytic


Therapeutic Actions

Anticholinergic, chemically related to atropine, which blocks vagally mediated reflexes by antagonizing the action of acetylcholine.
Causes bronchodilation and inhibits secretion from serous and seromucous glands lining the nasal mucosa.


Indications



  • Bronchodilator for maintenance treatment of bronchospasm associated with COPD (solution, aerosol), chronic bronchitis, and emphysema


  • Nasal spray: Symptomatic relief of rhinorrhea associated with perennial rhinitis, common cold, seasonal allergic rhinitis



Contraindications and Cautions



  • Contraindicated with hypersensitivity to atropine or its derivatives, soybean or peanut allergies (aerosol).


  • Use cautiously with narrow-angle glaucoma, prostatic hypertrophy, bladder neck obstruction, pregnancy, lactation.


Available Forms

Aerosol—17 mcg/actuation; solution for inhalation—0.02%; (500 mcg/vial); nasal spray—0.03% (21 mcg/spray), 0.06% (42 mcg/spray)


Dosages

Aerosol

Adults

The usual dosage is 2 inhalations qid. Patients may take additional inhalations as required. Do not exceed 12 inhalations/24 hr.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Nitrates
  2. Aldesleukin
  3. Ampicillin
  4. Aztreonam

Stay updated, free articles. Join our Telegram channel
Tags:
Jul 21, 2016 | Posted by in NURSING | Comments Off on Ipratropium Bromide

Full access? Get Clinical Tree
Get Clinical Tree app for offline access